NCT04630353 2025-09-12
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
Hookipa Biotech GmbH
Phase EARLY_PHASE1 Terminated
Hookipa Biotech GmbH
Shanghai Yunying Medical Technology
Shanghai OriginCell Therapeutics Co., Ltd.